Stockscreener 앱 받기
1.01
3.81%
-0.04
시장 영업 전:
1.00
-0.01
-0.99%
전일 마감가:
$1.05
열려 있는:
$1.06
하루 거래량:
252.29K
Relative Volume:
0.13
시가총액:
$13.07M
수익:
-
순이익/손실:
$-9.70M
주가수익비율:
-0.9182
EPS:
-1.1
순현금흐름:
$-8.57M
1주 성능:
+5.77%
1개월 성능:
+11.09%
6개월 성능:
-1.94%
1년 성능:
-59.44%
1일 변동 폭
$0.991
$1.094
1주일 범위
$0.9672
$1.13
52주 변동 폭
$0.8099
$5.95
마커 테라퓨틱스 Stock (MRKR) Company Profile
명칭
Marker Therapeutics Inc
전화
(713) 400-6400
주소
2450 HOLCOMBE BLVD, HOUSTON, TX
MRKR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.01 | 13.59M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
마커 테라퓨틱스 Stock (MRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Canaccord Genuity | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Overweight |
| 2021-03-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 개시 | ROTH Capital | Buy |
| 2019-03-01 | 개시 | Janney | Buy |
| 2018-12-03 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
마커 테라퓨틱스 주식(MRKR)의 최신 뉴스
Developing predictive dashboards with Marker Therapeutics Inc. dataJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com
Using R and stats models for Marker Therapeutics Inc. forecastingBuy Signal & Comprehensive Market Scan Insights - newser.com
What valuation multiples suggest for Marker Therapeutics Inc. stockPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Marker Therapeutics Inc. stock retracement – recovery analysisQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Volatility clustering patterns for Marker Therapeutics Inc.Dip Buying & Fast Gain Stock Tips - newser.com
Why retail investors pile into Marker Therapeutics Inc. stock2025 Top Gainers & High Win Rate Trade Tips - newser.com
Marker Therapeutics Inc. stock daily chart insightsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Real time breakdown of Marker Therapeutics Inc. stock performanceJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Best data tools to analyze Marker Therapeutics Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
What makes Marker Therapeutics Inc. (GX1) stock appealing to growth investorsJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program - Sahm
Marker Therapeutics Advances Off-the-Shelf T Cell Therapy with First Patient Treatment - TipRanks
Marker Therapeutics Launches Phase 1 RAPID Trial for Multi-Antigen Recognizing T Cells as Off-the-Shelf Treatment for AML and MDS - Quiver Quantitative
100x10^6‑cell initial dose: Marker Therapeutics treats first patient with MT‑401 in Phase 1 OTS RAPID study - Stock Titan
Marker Therapeutics Inc GX1 Stock Analysis and ForecastSwing Trading Watchlist & Exceptional Capital Trading - earlytimes.in
Is Marker Therapeutics Inc. trending in predictive chart models2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Will Marker Therapeutics Inc. stock maintain momentum in 2025Quarterly Portfolio Summary & Daily Entry Point Alerts - newser.com
How forex fluctuations impact Marker Therapeutics Inc. (GX1) stockMarket Risk Report & AI Enhanced Execution Alerts - newser.com
Will Marker Therapeutics Inc. (GX1) stock split increase liquidity2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Is Marker Therapeutics Inc. (GX1) stock worth holding before Fed meeting2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Is Marker Therapeutics Inc. (GX1) stock prepared for digital transition2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
Visualizing Marker Therapeutics Inc. stock with heatmapsJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
마커 테라퓨틱스 (MRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
마커 테라퓨틱스 주식 (MRKR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| New Enterprise Associates 16, | 10% Owner |
Dec 23 '24 |
Buy |
3.20 |
554,250 |
1,773,600 |
1,625,678 |
5.74%
자본화:
|
볼륨(24시간):